Hindustan Bio Sciences shareholders approved a special resolution for the reduction of share capital during the company's 34th Annual General Meeting held on September 30, 2026. The meeting also saw the reappointment of director Uma Jampana and the adoption of audited financial statements for FY26.

The meeting was chaired by J.V.R. Mohan Raju, Chairman and Managing Director, at the company's registered office in Hyderabad. Out of 12,039 shareholders on the record date, 39 attended physically, comprising four from the promoter group and 35 public shareholders. The quorum requirements were met, allowing the proceedings to commence at 10:00 am.

Resolutions Passed

Three key items of business were transacted via ballot and remote e-voting through CDSL:

1. Adoption of the Audited Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement for the year ended March 31, 2026.
2. Reappointment of Uma Jampana (DIN: 00912376) as a director retiring by rotation.
3. Approval of the Scheme of Reduction of Share Capital, which required a special resolution.

Governance and Attendance

The Board of Directors appointed VBSS Prasad as the Scrutinizer to oversee the voting process. The statutory auditor, VASG & Associates, reported that the audit opinion on the financial statements contained no qualifications, reservations, or adverse remarks. The meeting concluded at 10:45 am, with voting results to be announced within two working days.

Hindustan Bio Sciences Limited’s board of directors approved a scheme for the reduction of capital and reorganization of share capital in its meeting held on Monday, August 31, 2026. The move aims to set off accumulated losses and improve the company’s net worth.

The proposal involves the cancellation and extinguishment of 56,37,940 fully paid-up equity shares of ₹2 each on a pro-rata basis. This will reduce the paid-up equity share capital from ₹2,05,01,600 to ₹92,25,720. The company intends to set off ₹1,12,75,880 against its total accumulated losses of ₹1,22,41,849.

Capital Restructuring Details

Following the capital reduction, the company will consolidate its existing face value of ₹2 per share into ₹10 per share. Every five equity shares of ₹2 each after reduction will be consolidated into one equity share of ₹10 each.

Shareholders on the record date will receive nine equity shares of ₹10 each against every 100 equity shares of ₹2 each held. Fractional entitlements, if any, will be rounded off to one share. The promoter, Mr. Venkata Rama Mohan Raju Jampana, has agreed to forgo the increase in shares due to rounding off to keep the paid-up capital intact at ₹92,25,720.

Regulatory Approvals Required

The approved scheme is subject to necessary approvals from shareholders, the Hyderabad Bench of the National Company Law Tribunal (NCLT), and other statutory and regulatory bodies. The draft scheme will be made available on the company’s website after filing with BSE Limited.

AGM Notice

The board also considered the notice for convening the Annual General Meeting (AGM) for the financial year 2025-26. The meeting concluded at 4:30 pm. J V R Mohan Raju, Managing Director, signed the intimation letter dated August 31, 2026.